The webinar is part of a series of webinars, organised by the Healthcare and Life Sciences Committee, that intends to capture the actual influence of the Covid-19 pandemic on the regulatory approval paths for medicine, medical devices, diagnostics and vaccines; as well as on clinical trials around the world. The speakers will also propose alternative regulatory routes which are required in order to fight the pandemic or at the least enable a routine life in this unstable period.
Approval of drugs, devices and vaccines, as well as the continuing conduct of clinical trials, has tremendous importance for everyone’s lives these days. A worldwide view of the policies in place or being developed by regulatory authorities in different jurisdictions may contribute to a dialogue about ‘best practices' in the context of the pandemic.
Certificate of Attendance
Certificates of attendance for this webinar will be provided to all IBA members who have registered in advance and attended the live broadcast for a minimum of 30 minutes based on verified sign-in and sign-out times. Certificates can only be issued to the name provided at the time of registration.
Currently only IBA members will be provided with a certificate free of charge. IBA members should use the email address you have on file with the IBA to register for this webinar if you require a certificate of attendance.
Certificates for non-members are chargeable, please make enquiries at webinars@int-bar.org.
Sharon Gazit
Goldfarb Seligman & Co, Tel Aviv; Co-Chair, IBA Healthcare and Life Sciences Law Committee
Read biography
Professor Henry Cohen
Member, Honorary Scientific Committee - advising the Government of Uruguay on the strategy for Covid-19; Professor and Chairman of Gastroenterology, National University of Uruguay, Montevideo
Read biography